News About: Pharm. Industry
Unstoppable pharmaceutical stocks have been re-evaluated by potential values of its research and development
Stocks of pharmaceutical companies seem extraordinary lately. It is observed that increases affected by Hanmi Pharm have been extended to other stocks.
On the 25th, 4 items hit the ceiling price. Kyung Nam Pharm, The...
Pharmaceutical companies took 113 days to return payments of selling pharmaceutical products
It is known that it takes about 4 months for domestic pharmaceutical companies to collect payments made by selling pharmaceutical products last year.
According to the Medipana News’s analysis result of 55 listed phar...
The KJPA elected CEO Hae-do Jung as the president
The Korea Japanese Pharmaceutical Association, entering into Korea, appointed CEO Hae-do Jung of Astellas Pharma Korea as its president.
According to the Astellas Pharma Korea, CEO Hae-do Jung was elected to lead the...
Pfizer became the first company in invoices while Daewon Pharm recorded 20% upBased on its first generics and advanced drugs, a mid-sized company, Daewon Pharm, was the most notable company among the 30 companies in performance.
Last year, companies, suc...
|
MSD Korea acquired an approval for its anti PD-1 antibody from the Ministry of Food and Drug Safety
“We will represent changes of the paradigm with our 3rd generation anticancer drug overcoming side effects of systemic cancer chemotherapy and tolerance risks of targeted argents.”
MSD Korea (CEO Dong-wook Hyun) acqu...
The founding rate of the pharmaceutical industry has decreased for 4 consecutive years
Not only is the founding rate of the pharmaceutical industry low, but is it also decreasing.
The Korea Health Industry Development Institute has recently unveiled the fact through the report called the ‘Founding Stat...
The Korea Pharmaceutical Manufacturers Association will enforce the secret voting to sort out rebate-suspicious companies
It seems that the pharmaceutical industry will conduct a secret vote to sort out companies operating rebate businesses as scheduled in April.
According to the industry concerned, the Korea Pharmaceutical Manufacturer...
Advertising expenses of listed pharmaceutical companies exceeded KRW 400 billion last year
It is studied that listed pharmaceutical companies spent more than KRW 400 billion for advertisements due to several reasons such as invigoration of OTC drugs diversification of advertisement channels.
Moreover, it i...
On the controversy over the Ildong Pharmaceutical’s management against Green Cross, Ildong was able to smileIldong Pharmaceutical has successfully defended the management.
The proposal to appoint internal director (CEO and president Jung-chi Lee of Ildong Pharmaceutical) and outside ...
|
New changes are expected as emergence of internal promotions, recruits, a woman and second generations as CEOs
Approximately 40 pharmaceutical companies held shareholders’ general meetings and board meetings on the last 20th, the first woman professional manager has emerged, and personnel from multinational pharmaceutical comp...
